Psychedelic treatment modalities have had a long, bumpy history riddled with misinformation, stigma and politics. Despite the hurdles, courageous grassroots movements and the best minds in science persisted. The stigma around psychedelic treatments is beginning to lift. We?re seeing astounding outcomes in trials measuring the therapeutic use of MDMA, psilocybin, ketamine, and more. They are reversing mental illness from PTSD to depression offering hope to patients across the world. FDA approval of these groundbreaking therapies will be the watershed moment so sorely needed in mental and behavioral health. It?s time we bring psychedelics into the mainstream conversations happening across healthcare.